These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Potential antitumor agent dicyclohexylammonium 2-(4-N,N-bis(2-chloroethyl) amino)phenoxy)-2-methylpropionate. Sommer HZ; Wicks GE J Med Chem; 1972 Apr; 15(4):436-7. PubMed ID: 5019572 [No Abstract] [Full Text] [Related]
30. Antitumor imidazotetrazines. 41. Conjugation of the antitumor agents mitozolomide and temozolomide to peptides and lexitropsins bearing DNA major and minor groove-binding structural motifs. Arrowsmith J; Jennings SA; Clark AS; Stevens MF J Med Chem; 2002 Dec; 45(25):5458-70. PubMed ID: 12459014 [TBL] [Abstract][Full Text] [Related]
32. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Stevens MF; Hickman JA; Langdon SP; Chubb D; Vickers L; Stone R; Baig G; Goddard C; Gibson NW; Slack JA Cancer Res; 1987 Nov; 47(22):5846-52. PubMed ID: 3664486 [TBL] [Abstract][Full Text] [Related]
33. Cytostatic effect of homo-aza-steroidal esters in vivo and in vitro. Structure-activity relationships. Catsoulacos P; Camoutsis C; Papageorgiou A; Adamiak-Margariti E Anticancer Res; 1992; 12(5):1617-20. PubMed ID: 1444229 [TBL] [Abstract][Full Text] [Related]
34. Acridine derivatives. III. Preparation and antitumor activity of the novel acridinyl-substituted uracils. Kimura M; Okabayashi I; Kato A Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):697-701. PubMed ID: 2752480 [TBL] [Abstract][Full Text] [Related]
35. [The synthesis and carcinostatic effect of 4-[bis-(2-chloroethyl)-amino]-2, 3-dimethyl-1-phenyl-5-pyrazolone ("imet 3995")]. Werner W; Jungstand W; Gutsche W; Wohlrabe K Pharmazie; 1975 Jul; 30(7):433-5. PubMed ID: 1178756 [No Abstract] [Full Text] [Related]
37. Metabolism and murine pharmacokinetics of the 8-(N,N-dimethylcarboxamide) analogue of the experimental antitumor drug mitozolomide (NSC353451). Horspool KR; Quarterman CP; Slack JA; Gescher A; Stevens MF; Lunt E Cancer Res; 1989 Sep; 49(18):5023-6. PubMed ID: 2766272 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, structure-activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents. Li DD; Dai LL; Zhang N; Tao ZW Bioorg Med Chem Lett; 2015 Oct; 25(19):4092-6. PubMed ID: 26299348 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and bioevaluation of a series of fatty acid esters of p-[N,N-bis(2-chloroethyl)amino]phenol. Wynn JE; Caldwell ML; Robinson JR; Beamer RL; Bauguess CT J Pharm Sci; 1982 Jul; 71(7):772-6. PubMed ID: 7120060 [TBL] [Abstract][Full Text] [Related]
40. Anti-tumour imidazotetrazines. Part XXI. Mitozolomide and temozolomide: probes for the major groove of DNA. Clark AS; Stevens MF; Sansom CE; Schwalbe CH Anticancer Drug Des; 1990 Feb; 5(1):63-8. PubMed ID: 2317259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]